Co-administration of Shingles and RSV Vaccines Produces …
WEB4 hours ago · GSK plc recently announced topline Phase 3 clinical trial data for a combination regimen of two of its vaccines: the RSV vaccine Arexvy and Shingrix, a market-leading shingles shot. While GSK did not provide specific clinical trial (NCT05966090) data in its September 18, 2024 announcement, the company did confirm that co-administering Arexvy with Shingrix resulted in a “non-inferior immune ...
Phase 3 Study Displays Positive Results of Co-Administration of …
WEB1 day ago · Aimed to provide a more convenient vaccination regimen, researchers conducted a phase 3, open-label, multi-country study that assessed non-inferiority of immune responses in co-administered RSV and shingles vaccine compared with separate administration among adults 50 years and older. 1. The …
Shingles infection linked to risk of cognitive decline, says study ...
WEBGetting shingles just once could increase the risk of long-term confusion and memory loss, a new study has found. The researchers and other doctors discuss why there may be an association.
GSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines
WEB7 hours ago · GSK plc GSK announced positive topline results from a phase III study evaluating the co-administration of its two marketed vaccines — RSV vaccine Arexvy and shingles vaccine Shingrix — in ...
Shingles may increase risk of cognitive decline - Harvard Gazette
WEBAug 20, 2024 · A new study has found that an episode of shingles is associated with about a 20 percent higher long-term risk of subjective cognitive decline, one of the earliest noticeable symptoms of Alzheimer’s disease and related dementias.
Shingles vaccines may reduce dementia risk, two large new …
WEBJul 30, 2024 · CNN — Two new studies suggest that getting a vaccine to protect against a painful case of shingles may be beneficial for memory, too. An estimated 98% of US …
New shingles vaccine could reduce risk of dementia - University …
WEBJul 25, 2024 · The new recombinant shingles vaccine ‘Shingrix’ is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study published in Nature Medicine. It is also more …
Large study of shingles vaccine finds strong effectiveness over 4 …
WEBJan 8, 2024 · The vaccine currently used to protect people against shingles maintains strong effectiveness over 4 years post-vaccination, according to a Kaiser Permanente-led research study published in Annals of Internal Medicine.
New Shingles Vaccine FAQ | Shingrix - Consumer Reports
WEBJan 25, 2018 · Today, the Centers for Disease Control and Prevention made its formal recommendations for the use of Shingrix —a new vaccine that appears to offer …
Mayo Clinic Q and A: New shingles vaccine recommended for …
WEBJun 15, 2018 · ANSWER: A new vaccine, called Shingrix, is now available that’s very effective in preventing shingles. The Centers for Disease Control and Prevention (CDC) recommends that everyone age 50 and older with a healthy immune system receive this vaccine, whether you’ve had shingles before or not.
Skip to content